European Neuropsychopharmacology 1994-06-01

Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol.

W H Chang, Y S Shieh, H C Liu, M W Jann, C P Chien

Index: Eur. Neuropsychopharmacol. 4(2) , 119-26, (1994)

Full Text: HTML

Abstract

Plasma haloperidol (HL) and reduced haloperidol (RH) levels were measured in 60 schizophrenic patients treated with high to very high HL doses of 40-200 mg/day. Plasma samples were obtained at steady-state conditions and 10-12 h after the evening dose and prior to the morning dose. RH/HL ratios were shown to be dose-dependent. In the lowest dose group of 40-45 mg/day, 77% of the patients had RH/HL ratios < 1.0. At the higher dose of 60-80 mg/day, these results were reversed as 79% of the patients had RH/HL ratios > 1.0. All patients with HL doses greater than 100 mg/day had RH/HL ratios > 1.0. All patients safely tolerated the high haloperidol dosages and only five patients had extrapyramidal side effects that were unresponsive to trihexyphenidyl. Therapeutic improvement was not observed in each patient. Based upon the dose-dependent increase in the RH/HL ratios in schizophrenic patients, the possible mechanism of a 'therapeutic' window for HL is discussed.

Related Compounds

  • Haloperidol Metab...

Related Articles:

Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.

2009-07-01

[Psychopharmacology 205 , 21-33, (2009)]

Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.

2006-10-01

[Anal. Bioanal. Chem 386(3) , 719-24, (2006)]

Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.

1999-07-01

[Int. Clin. Psychopharmacol. 14(4) , 219-28, (1999)]

Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia.

1994-03-01

[Prog. Neuropsychopharmacol. Biol. Psychiatry 18(2) , 347-53, (1994)]

Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.

2000-06-01

[Ther. Drug Monit. 22(3) , 245-9, (2000)]

More Articles...